MedTech Innovator Announces 2024 Grand Prize and Execution Award Finalists

World’s largest medtech accelerator has fostered more than 700 companies, representing 350 FDA approvals and clearances, and securing over $8 billion in follow-on funding

LOS ANGELES – September 26, 2024 – MedTech Innovator (MTI), the world’s largest accelerator of medical technology companies, today announced the finalists in its Grand Prize competition for early-stage medtech startup companies in the culmination of its 2024 MTI Accelerator program. Each finalist will receive $25,000 and compete for the $350,000 non-dilutive Grand Prize at The MedTech Conference powered by AdvaMed, October 15-17, in Toronto. During the competition finals, which will be held in the Keynote Theater on Wednesday, October 16, at 4:00 pm ET, each of the five companies will pitch their value proposition and answer questions from a panel featuring industry experts representing some of the largest medtech companies in the world. After the presentations, the conference audience will vote in real time to select the winner.

The five finalists who will compete for the 2024 Early-Stage Grand Prize are:

• BrainSpace (Seattle): a wearable continuous ICP monitor & automated CSF drain, freeing up ICU beds and generating AI-ready data.
• Flow Medical (Chicago): a next-generation PE Thrombolysis catheter with a novel design to infuse thrombolytic agents and real-time hemodynamic monitoring to personalize medicine for each patient.
• Juniper Biomedical (Worcester, Mass.): a unique, implantable neuromodulation platform to dramatically improve the treatment of urinary incontinence and other pelvic health conditions. 
• NeuroBionics (Cambridge, Mass.): a device for minimally-invasive endovascular deep brain stimulation to enhance stroke rehabilitation outcomes for patients.  
• Samay (Mountain View, Calif. and Medellín, Colombia): acoustic resonance patches for COPD diagnosis, management, and intervention.

“At MTI, we spend the entire year working closely with the industry’s leading medtech companies to curate and accelerate market access for the world’s best-of-the-best medtech startups, and this year we selected 45 out of 1,400 applicants for the early-stage cohort of our US market-focused accelerator,” said Paul Grand, founder and Chief Executive Officer of MedTech Innovator. “After four months of mentoring, the senior leadership at our strategic partners championed 29 of their top mentees with only ten finalist slots in our two competitions, so you know these startups truly embody the potential to dramatically improve healthcare delivery and outcomes for millions of patients worldwide.”

In addition to the Grand Prize, five companies will compete for the Execution Award, presented jointly by AdvaMed Accel and MedTech Innovator. The Execution Award recognizes strong leadership teams with value-adding innovations and a demonstrated track record of successfully executing their plan to improve patient care. The Execution Award winner will be selected by the audience at The MedTech Conference and receive $25,000.

The five finalists for the 2024 Execution Award are:

• AccurKardia (New York): ECG-led diagnostics software unlocking the value of the ECG signal for broad diagnostics coverage and disease management, ultimately improving clinical outcomes and saving lives. 
• Akeyna (Boston): a unique smart needle that detects blood vessels to prevent severe complications such as blindness, which can occur when blood vessels are accidentally occluded with dermal fillers.
• iCE Neurosystems (Washington): a comprehensive device-and-data platform to revolutionize brain care in critically ill patients.
• SanaHeal (Cambridge, Mass.): a novel bioadhesive biomaterial platform to revolutionize the treatment of bleeding, wounds, and the mechanical integration of devices into the human body.
• Vonova (San Diego): a minimally-invasive platform for treating chronic neurological disorders without the risk and cost of drilling through the skull.

This year, MTI tapped over five hundred subject matter experts to evaluate thousands of applicants and mentor the best-in-class 65 companies participating in MTI’s flagship four-month US market-focused accelerator program. Featuring 45 early-stage and 20 mid-stage medical device, diagnostic, and digital health companies from around the globe, the 2024 cohort company leadership teams received unparalleled mentoring, networking, and access to the resources that only MTI’s world-leading ecosystem of strategic manufacturers, investors, healthcare providers, payers, patients, and other industry stakeholders can offer. All 65 companies will be showcased at The MedTech Conference in Toronto, and four mid-stage companies will compete in the Mid-stage Finals during the MedTech Strategist Innovation Summit on November 19-21 in San Diego.

About MedTech Innovator

MedTech Innovator (MTI) is the world’s largest accelerator of medical technology companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, reviewing nearly 12,000 applicants and fostering the growth of 717 companies that have collectively raised over $8 billion in follow-on funding after graduating from MTI and introducing 350+ products to the market, transforming the lives of millions.

For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow them on LinkedIn, and subscribe to its monthly newsletter.

MEDIA CONTACTS:

Branden Morris
MedTech Innovator
branden@medtechinnovator.org
978- 770-3799

Helen Shik
Pazanga Health Communications
hshik@pazangahealth.com
617-510-4373